Anshul Saigal of Saigal Capital sees strong multi-sector tailwinds in India’s markets, driven by infrastructure revival, renewable energy, and pharma growth. Despite SEBI’s proposed AMC fee cuts, he believes long-term wealth creation remains intact. Saigal expects cement, metals, and CDMO pharma to outperform, marking the start of India’s next major investment cycle.Read More
Groww’s upcoming IPO is drawing strong interest, with a grey market premium of ₹10.5 indicating potential listing gains of around 10%. The fintech’s debut could value it at nearly ₹70,400 crore ($8 billion).Read More
Singapore-based conglomerate Keppel reported a 25% rise in net profit for the first nine months of 2025 on Thursday, aided by strong earnings growth across all its three business segments and higher recurring income.Read More
Oyo’s parent company, PRISM, is boosting its share capital. This move signals advanced preparations for its upcoming Initial Public Offering. The company is also issuing sweat equity to independent directors. Bonus shares will be distributed to existing shareholders. PRISM recently reported strong financial growth, with profits and revenue significantly increasing.Read More
Hyundai Motor India is expected to report a modest Q2 FY26 performance, with profit rising around 10% YoY and revenue remaining largely flat. Brokerages project margin expansion driven by higher SUV sales, cost control, and export growth, even as domestic demand stays soft. The Creta and Venue are expected to anchor profitability amid rising competition.Read More
Shares of Vijay Kedia-backed Vaibhav Global surged 13% after the company posted strong Q2 FY26 results, driven by 10% revenue growth, a 71% jump in profit, and margin expansion to 10%. Robust digital sales, higher in-house brand contribution, and a strong balance sheet underpinned performance. The stock has gained nearly 30% in the past month.Read More
Bitcoin dropped 3.5% to below $109,000, dragging the global crypto market cap under $4 trillion after the Fed’s rate cut. Ethereum and major altcoins also fell over 3–4%, with total market value slipping to $3.68 trillion.Read More
Dr. Reddy’s Laboratories shares declined over 5% after receiving a Notice of Non-Compliance from Canada’s Pharmaceutical Drugs Directorate for its Semaglutide Injection, though analysts see the issue as temporary.Read More
Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada.